Comparison of hospital treatment strategy or of treatment actually received in COVID-19?: Commenting on: Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, et al. Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients. Int J Infect Dis. 2020 September.

Sikkens, Jonne J; Collard, Didier; Peters, Edgar J G

Sikkens, Jonne J; Collard, Didier; Peters, Edgar J G.

Sikkens JJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands. Electronic address: j.sikkens@amsterdamumc.nl.
Collard D; Amsterdam UMC, University of Amsterdam, Department of Vascular Medicine, Amsterdam Cardiovascular Sciences, Meibergdreef 9, Amsterdam, The Netherlands.
Peters EJG; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Internal Medicine, Amsterdam Infection and Immunity Institute, De Boelelaan 1117, Amsterdam, The Netherlands.

Int J Infect Dis ; 103: 516, 2021 02.

Article in English | MEDLINE | ID: covidwho-1120390

Subject(s)

COVID-19 Drug Treatment; Hydroxychloroquine; Chloroquine/therapeutic use; Hospitals; Humans; Hydroxychloroquine/therapeutic use; Intensive Care Units; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment / Hydroxychloroquine Limits: Humans Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google